MAPT and Alzheimer disease: Pathologically, various studies have indicated that miR-132 is the most common downregulated miRNA in the postmortem AD brain, and is involved in the progression of Aβ and tau pathology (Lau et al., 2013; Patrick et al., 2017; Pichler et al., 2017).